Ann Nanosci Nanotechnol | Volume 3, Issue 1 | Research Article | Open Access

Potential and Theranostics Applications of Novel Anti Cancer Nano Drugs Delivery Systems in Preparing for Clinical Trials of Synchrotron Microbeam Radiation Therapy (SMRT) and Synchrotron Stereotactic Radiotherapy (SSRT) for Treatment of Human Cancer Cells, Tissues and Tumors Using Image Guided Synchrotron Radiotherapy (IGSR)

Alireza Heidari*

Faculty of Chemistry, California South University, USA

*Correspondance to: Alireza Heidari 

Fulltext PDF

Abstract

Novel anti-cancer Nano drugs delivery systems in preparing for clinical trials of Synchrotron Microbeam Radiation Therapy (SMRT) and Synchrotron Stereotactic Radiotherapy (SSRT) are the most promising human cancer cells, tissues and tumors treatment to be developed in the past decade. The current Image-Guided Synchrotron Radiotherapy (IGSR) market is over $1000 billion. There have been over 25 FDA approvals for Image-Guided Synchrotron Radiotherapy (IGSR) in the past year alone, and several pharmaceutical companies are heavily vested in developing their own synchrotron radiotherapies for human cancer cells, tissues and tumors treatment using Image-Guided Synchrotron Radiotherapy (IGSR) and imaging. Unfortunately, the percentage of human cancer patients for whom this treatment works remains modest. Novel anti-cancer Nano drugs delivery systems can be utilized to increase the efficacy of tumor Image-Guided Synchrotron Radiotherapy (IGSR) in the unresponsive patient population by altering the localization and pharmacokinetics of the therapeutic agents. In this paper, we would like to provide a condensed review of the current trends in potential and theranostics applications of novel anti-cancer Nano drugs delivery systems in preparing for clinical trials of Synchrotron Microbeam Radiation Therapy (SMRT) and Synchrotron Stereotactic Radiotherapy (SSRT) for treatment of human cancer cells, tissues and tumors using Image-Guided Synchrotron Radiotherapy (IGSR) and imaging research, promising new approaches, and conclude by emphasizing on both the importance of novel anticancer Nano drugs delivery systems in preparing for clinical trials of Synchrotron Microbeam Radiation Therapy (SMRT) and Synchrotron Stereotactic Radiotherapy (SSRT) for treatment of human cancer cells, tissues and tumors using Image-Guided Synchrotron Radiotherapy (IGSR) and imaging as well as some of the existing hurdles in translation of these technologies into the clinic

Keywords:

Proton beam therapy; Synchrotron radiation therapy; IGSR; SMRT; SSRT; Novel anti-cancer nano drugs; Tissues and tumors

Citation:

Heidari A. Potential and Theranostics Applications of Novel Anti Cancer Nano Drugs Delivery Systems in Preparing for Clinical Trials of Synchrotron Microbeam Radiation Therapy (SMRT) and Synchrotron Stereotactic Radiotherapy (SSRT) for Treatment of Human Cancer Cells, Tissues and Tumors Using Image Guided Synchrotron Radiotherapy (IGSR). Ann Nanosci Nanotechnol. 2019;3(1):1006.

Subscribe to Our Newsletter